Thus, elevated IL-10, a marker of the inflammatory pathway leading to mortality in ALS, was downregulated post-CBIT2, suggesting a potential shift away from fatal progression for the patient. This evidence concerns the gene IL10 and amyotrophic lateral sclerosis.